Austin, Texas, October 7th, 2026, FinanceWireVERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based ...
Session: Advances in Oncology Panel Presenter: Walter Klemp, Chairman and Chief Executive Officer of Moleculin Date/time: Wednesday, October 14, 2026, from 9:00 - 10:00 a.m. ET Location: NYY Room at ...
Oneness Biotech completed the SAD portion of its Phase 1 trial evaluating SNS851 as a potential treatment for ...
VERAXA Biotech (NASDAQ: VRXA) is shifting its focus to advancing its oncology pipeline and implementing industrial ...
The global white biotechnology market is forecast to expand from USD 334.755 billion in 2025 to USD 541.097 billion by 2031, representing a compound annual growth rate of 8.33%. Market growth is being ...
A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus on plants at the molecular level, paving the way for next-generation crop ...
Hosted on MSN
ATGC Biotech showcases India’s agri-biotech innovation at Bharat Innovates 2026, advances global partnerships
Selected among 120 high-potential deep-tech startups representing India at Bharat Innovates 2026 in Nice, France ATGC Biotech Pvt. Ltd., an Indian deep-tech agricultural biotechnology company ...
The life sciences industry is experiencing transformative shifts driven by technological innovation and urgent global health needs. AAA Biotech, a leading provider of premium research reagents, is ...
TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
Oncolytics Biotech remains in focus as the cancer-focused biotech advances its oncolytic virus pelareorep through multiple clinical trials, including breast and gastrointestinal cancer studies, ...
VERAXA Biotech (NASDAQ: VRXA) is shifting its focus to advancing its oncology pipeline and implementing industrial ...
(MENAFN- GlobeNewsWire - Nasdaq) Demand for low-carbon biofuels, bioplastics, chemicals and enzymes is rising, fueled by policy and biotech advances. Asia-Pacific offers strong scaling opportunities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results